Spotlight Innovation Inc. (OTCQB: STLT) engages in the identification and acquisition of innovative and proprietary cancer treatment technologies. Shares of the cancer treatment company are rallying 10%, through afternoon trading on Wednesday, October 12, 2016. Over the past three months, Spotlight Innovations Inc. has seen average daily volume of 12,035 shares. However, nearly 83,900 shares or dollar volume of $83,061, has already exchanged hands through early trading Wednesday.

Shares of Spotlight Innovation Inc. are rallying Wednesday, after the company announced it will be presenting at the Fall SeeThruEquity Microcap Investor Conference. The conference will be held on October 17, 2016 at the Convene Grand Central in New York City. The company will have 30 minutes to present on operations, developments, updates to industry professionals and investors. Here is the press release detailing of the investor conference:

Spotlight Innovation Inc. Press Release:

 WEST DES MOINES, Iowa, Oct. 12, 2016 /PRNewswire/ — Spotlight Innovation Inc. (STLT) today announced that the Company will present at the Fall SeeThruEquity Microcap Investor Conference being held at Convene Grand Central located at 101 Park Avenue in New York City on October 17, 2016.

During Spotlight Innovation’s 30-minute presentation, which begins at 10:30 a.m. ET, management will provide an overview of Company activities to an audience of investors and industry professionals. Company management will also be available for one-on-one meetings with institutional investors.

About SeeThruEquity

Since the company’s founding in 2011, SeeThruEquity (STE) has been committed to its core mission: providing impactful, high quality research on uncovered and undercovered microcap stocks and hosting investor conferences throughout the year. STE has been able to grow its research universe to over 190 names. STE conferences are the ultimate event for publicly traded companies with less than $1 billion in market capitalization because it augments the conference experience with the firm’s research which is part of Wall Street consensus and available across industry leading platforms including Thomson First Call, FactSet, S&P CapitalIQ, Yahoo! Finance and Bloomberg to name a select few.  STE has hosted 20 investor conferences which have showcased over 350 companies, attracted over 4500 attendees and have included over 1,700 1-on-1 meetings.

For more information please visit

About Spotlight Innovation Inc.

Spotlight Innovation Inc. (STLT) identifies and acquires rights to innovative, proprietary technologies designed to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. To find and evaluate unique opportunities, we leverage our extensive relationships with leading scientists, academic institutions and other sources. We provide value-added capability to accelerate development progress. When scientifically significant benchmarks have been achieved, we will endeavor to partner with proven market leaders via sale, out-license or strategic alliance. For more information, visit or follow us on

Add a Comment to this Post